Mereo BioPharma Group PLC ADR (MREO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $49.11M
Last updated: Nov 17, 2026 at 11:01 AM ET
Mereo BioPharma Group PLC ADR (MREO) Competitors
The companies most similar to Mereo BioPharma Group PLC ADR are Mural Oncology (MURA), Spero Therapeutics (SPRO) and Biomea Fusion (BMEA). By market cap, Mereo BioPharma Group PLC ADR ranks 5th of the 13 companies on this page; Neumora Therapeutics (NMRA) is the largest at $80.59M.
Peer Comparison
MREO's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Mereo BioPharma Group PLC ADR (MREO) | $49.11M | N/A | 61.3x | 0.0% | -116.6% | 0.0% | 0.00% |
| Mural Oncology plc (MURA) | $35.38M | N/A | N/A | 0.0% | -173.6% | 0.0% | 0.00% |
| Spero Therapeutics Inc (SPRO) | $58.26M | 11.1x | 1.3x | 15.7% | N/A | -95.6% | 0.00% |
| Biomea Fusion Inc (BMEA) | $42.31M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| MAIA Biotechnology Inc. (MAIA) | $61.75M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Veru Inc (VERU) | $35.64M | N/A | N/A | 0.0% | N/A | 18.3% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Neumora Therapeutics, Inc. (NMRA) | $80.59M | N/A | N/A | 0.0% | -260.5% | 0.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Immutep Ltd ADR (IMMP) | $25.64M | N/A | 2.2x | 0.0% | N/A | 633.0% | 0.00% |
| Oncolytics Biotech Inc (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $40.19M | 11.1x | 1.8x | 0.0% | -217.0% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Mereo BioPharma Group PLC ADR, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Mural Oncology plc (MURA) | Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors... | |
| Spero Therapeutics Inc (SPRO) | Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing... | SPRO competitors |
| Biomea Fusion Inc (BMEA) | Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat... | BMEA competitors |
| MAIA Biotechnology Inc. (MAIA) | MAIA Biotechnology Inc. is an innovative biotechnology company focused on developing cutting-edge cancer therapies that significantly improve patient outcomes... | MAIA competitors |
| Veru Inc (VERU) | Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. | VERU competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| Neumora Therapeutics, Inc. (NMRA) | Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases... | NMRA competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| Immutep Ltd ADR (IMMP) | Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. | |
| Oncolytics Biotech Inc (ONCY) | Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. | ONCY competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
Frequently Asked Questions About MREO
Who are Mereo BioPharma Group PLC ADR's main competitors?
The companies most similar to Mereo BioPharma Group PLC ADR include Mural Oncology (MURA), Spero Therapeutics (SPRO), Biomea Fusion (BMEA), MAIA Biotechnology (MAIA) and Veru (VERU), listed from the closest match.
Who is Mereo BioPharma Group PLC ADR's biggest competitor?
Neumora Therapeutics (NMRA) is the largest of the similar companies at $80.59M; Mural Oncology (MURA) is the closest match by business profile, size, sector and industry.
How does MREO stock compare with its competitors?
MREO's P/S is 61.3x against a peer median of 1.8x; its net margin is 0.0% against a peer median of 0.0%.
Which of Mereo BioPharma Group PLC ADR's competitors pays a higher dividend?
Mereo BioPharma Group PLC ADR pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Mereo BioPharma Group PLC ADR bigger than its competitors?
No. Mereo BioPharma Group PLC ADR is 5th by market cap among the 13 companies on this page; the largest is Neumora Therapeutics (NMRA) at $80.59M.
MREO pages: Overview, Competitors